» Articles » PMID: 12162506

Alleles of RUNX2/CBFA1 Gene Are Associated with Differences in Bone Mineral Density and Risk of Fracture

Overview
Date 2002 Aug 7
PMID 12162506
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to determine if DNA polymorphism within runt-related gene 2 (RUNX2)/core binding factor A1 (CBFA1) is related to bone mineral density (BMD). RUNX2 contains a glutamine-alanine repeat where mutations causing cleidocranial dysplasia (CCD) have been observed. Two common variants were detected within the alanine repeat: an 18-bp deletion and a synonymous alanine codon polymorphism with alleles GCA and GCG (noted as A and G alleles, respectively). In addition, rare mutations that may be related to low BMD were observed within the glutamine repeat. In 495 randomly selected women of the Geelong Osteoporosis Study (GOS), the A allele was associated with higher BMD at all sites tested. The effect was maximal at the ultradistal (UD) radius (p = 0.001). In a separate fracture study, the A allele was significantly protective against Colles' fracture in elderly women but not spine and hip fracture. The A allele was associated with increased BMD and was protective against a common form of osteoporotic fracture, suggesting that RUNX2 variants may be related to genetic effects on BMD and osteoporosis.

Citing Articles

A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis.

Block T, Shore-Lorenti C, Zebaze R, Kerr P, Kalff A, Perkins A JBMR Plus. 2023; 7(9):e10791.

PMID: 37701147 PMC: 10494497. DOI: 10.1002/jbm4.10791.


Evolution and expansion of the RUNX2 QA repeat corresponds with the emergence of vertebrate complexity.

Newton A, Pask A Commun Biol. 2020; 3(1):771.

PMID: 33319865 PMC: 7738678. DOI: 10.1038/s42003-020-01501-3.


A comprehensive overview on osteoporosis and its risk factors.

Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh Y Ther Clin Risk Manag. 2018; 14:2029-2049.

PMID: 30464484 PMC: 6225907. DOI: 10.2147/TCRM.S138000.


Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.

Saito A, Ooki A, Nakamura T, Onodera S, Hayashi K, Hasegawa D Stem Cell Res Ther. 2018; 9(1):12.

PMID: 29357927 PMC: 5778688. DOI: 10.1186/s13287-017-0754-4.


Enhancement of Bone Marrow-Derived Mesenchymal Stem Cell Osteogenesis and New Bone Formation in Rats by Obtusilactone A.

Lin Y, Chen C, Chou L, Chen C, Kang L, Wang C Int J Mol Sci. 2017; 18(11).

PMID: 29140298 PMC: 5713390. DOI: 10.3390/ijms18112422.